Europe – EMA cancer symposium: New approaches in patient-focused cancer medicine development

On Thursday, 29 October, EMA is hosting a symposium to discuss new approaches to facilitating and using input from cancer patients to inform medicine development and regulatory decision-making.

The  agenda of the symposium , which will be held virtually due to the ongoing pandemic is available. The event can be followed via live broadcast on the event page.

The purpose of the symposium is to identify opportunities and come up with recommendations to further advance patients’ contribution and involvement in data collection, development and evaluation of cancer treatments. This will help EMA to translate any recommendations into concrete actions to further improve cancer treatment development and regulation…